Apolar med dekvalin 1 mg/ g / 4 mg/ g 挪威 - 挪威文 - Statens legemiddelverk

apolar med dekvalin 1 mg/ g / 4 mg/ g

actavis group ptc ehf (1) - desonid / dekvaliniumklorid - salve - 1 mg/ g / 4 mg/ g

Elidel 10 mg/ g 挪威 - 挪威文 - Statens legemiddelverk

elidel 10 mg/ g

viatris as - pimecrolimus - krem - 10 mg/ g

Ibaril 2.5 mg/ g 挪威 - 挪威文 - Statens legemiddelverk

ibaril 2.5 mg/ g

sanofi-aventis norge (3) - desoksymetason - krem - 2.5 mg/ g

Evotaz 欧盟 - 挪威文 - EMA (European Medicines Agency)

evotaz

bristol-myers squibb pharma eeig - cobicistat, atazanavir - hiv-infeksjoner - antivirale midler til systemisk bruk - evotaz is indicated in combination with other antiretroviral medicinal products for the treatment of hiv-1 infected adults and adolescents (aged 12 years and older weighing at least 35 kg) without known mutations associated with resistance to atazanavir (see sections 4. 4 og 5.

Olumiant 欧盟 - 挪威文 - EMA (European Medicines Agency)

olumiant

eli lilly nederland b.v. - baricitinib - leddgikt, reumatoid - immunsuppressive - rheumatoid arthritisbaricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). olumiant kan brukes som monoterapi eller i kombinasjon med metotrexat. atopic dermatitisolumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older who are candidates for systemic therapy. alopecia areatabaricitinib is indicated for the treatment of severe alopecia areata in adult patients (see section 5. juvenile idiopathic arthritisbaricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic dmards:- polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [rf+] or negative [rf-], extended oligoarticular),- enthesitis related arthritis, and- juvenile psoriatic arthritis. baricitinib may be used as monotherapy or in combination with methotrexate.

Apolar 0.1 % 挪威 - 挪威文 - Statens legemiddelverk

apolar 0.1 %

teva b.v. - desonid - salve - 0.1 %

Apolar 0.1 % 挪威 - 挪威文 - Statens legemiddelverk

apolar 0.1 %

teva b.v. - desonid - krem - 0.1 %

Betnovat med Chinoform 1 mg/ g / 30 mg/ g 挪威 - 挪威文 - Statens legemiddelverk

betnovat med chinoform 1 mg/ g / 30 mg/ g

glaxosmithkline as - betametasonvalerat / kliokinol - krem - 1 mg/ g / 30 mg/ g

Altargo 欧盟 - 挪威文 - EMA (European Medicines Agency)

altargo

glaxo group ltd - retapamulins - impetigo; staphylococcal skin infections - antibiotika og kjemoterapeutiske midler til dermatologisk bruk - short term treatment of the following superficial skin infections: , impetigo;, infected small lacerations, abrasions or sutured wounds. se avsnitt 4. 4 og 5. 1 for viktig informasjon om den kliniske aktiviteten av retapamulin mot ulike typer av staphylococcus aureus. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.

Ledaga 欧盟 - 挪威文 - EMA (European Medicines Agency)

ledaga

helsinn birex pharmaceuticals ltd. - chlormethine - mycosis fungoides - antineoplastiske midler - ledaga er indikert for topisk behandling av mycosis fungoides-type kutant t-celle lymfom (mf-type ctcl) hos voksne pasienter.